A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

NCT06265727 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

348

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: CRB-701
DRUG: Anti-PD-1

Sponsor

Corbus Pharmaceuticals Inc.

Collaborators

[object Object]